FDA.reportPublic FDA data

Levo-T 300 MCG Oral Tablet

RxCUI
966214
RxNorm name
Levo-T 300 MCG Oral Tablet
Display name
Levo-T 300 MCG Oral Tablet
Full name
Levo-T 300 MCG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2085385a-7fe4-5bfe-e054-00144ff88e88Levo-T 300 MCG Oral Tablet [PSN] · levothyroxine sodium 0.3 MG Oral Tablet [Levo-T] [SBD] · Levo-T 0.3 MG Oral Tablet [SY] · Levo-T 300 MCG Oral Tablet [SY]418These highlights do not include all the information needed to use LEVO-T® safely and effectively. See full prescribing information for LEVO-T. LEVO-T® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval:200220240418